Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
Zavascki AP, Goldani LZ, Li J, Nation RL. Zavascki AP, et al. J Antimicrob Chemother. 2007 Dec;60(6):1206-15. doi: 10.1093/jac/dkm357. Epub 2007 Sep 17. J Antimicrob Chemother. 2007. PMID: 17878146 Review.
Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
Zavascki AP, Cruz RP, Goldani LZ. Zavascki AP, et al. J Hosp Infect. 2005 Feb;59(2):96-101. doi: 10.1016/j.jhin.2004.09.007. J Hosp Infect. 2005. PMID: 15620442
Severe acute hepatitis due to retroviral rebound syndrome after discontinuation of highly active antiretroviral therapy.
Zavascki AP. Zavascki AP. J Infect. 2006 Mar;52(3):e93-4. doi: 10.1016/j.jinf.2005.06.001. Epub 2005 Jul 18. J Infect. 2006. PMID: 16026841
Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
Zavascki AP. Zavascki AP. Clin Microbiol Infect. 2005 Oct;11(10):856-7. doi: 10.1111/j.1469-0691.2005.01246.x. Clin Microbiol Infect. 2005. PMID: 16153266 No abstract available.
Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. Zavascki AP, et al. J Antimicrob Chemother. 2005 Dec;56(6):1148-51. doi: 10.1093/jac/dki390. Epub 2005 Oct 20. J Antimicrob Chemother. 2005. PMID: 16239284
Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA.
Sandri AM, Dalarosa MG, Ruschel de Alcantara L, da Silva Elias L, Zavascki AP. Sandri AM, et al. Among authors: zavascki ap. Infect Control Hosp Epidemiol. 2006 Feb;27(2):185-7. doi: 10.1086/500625. Epub 2006 Feb 8. Infect Control Hosp Epidemiol. 2006. PMID: 16465636
The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, Ramos F, Goldani LZ. Zavascki AP, et al. J Antimicrob Chemother. 2006 Aug;58(2):387-92. doi: 10.1093/jac/dkl239. Epub 2006 Jun 3. J Antimicrob Chemother. 2006. PMID: 16751638
High prevalence of metallo-beta-lactamase-mediated resistance challenging antimicrobial therapy against Pseudomonas aeruginosa in a Brazilian teaching hospital.
Zavascki AP, Goldani LZ, Gonçalves AL, Martins AF, Barth AL. Zavascki AP, et al. Epidemiol Infect. 2007 Feb;135(2):343-5. doi: 10.1017/S0950268806006893. Epub 2006 Jul 7. Epidemiol Infect. 2007. PMID: 16824253 Free PMC article.
First case report of Neisseria lactamica causing cavitary lung disease in an adult organ transplant recipient.
Zavascki AP, Fritscher L, Superti S, Dias C, Kroth L, Traesel MA, Antonello IC, Saitovitch D. Zavascki AP, et al. J Clin Microbiol. 2006 Jul;44(7):2666-8. doi: 10.1128/JCM.00274-06. J Clin Microbiol. 2006. PMID: 16825411 Free PMC article.
Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study.
Zavascki AP, Barth AL, Fernandes JF, Moro AL, Gonçalves AL, Goldani LZ. Zavascki AP, et al. Crit Care. 2006;10(4):R114. doi: 10.1186/cc5006. Crit Care. 2006. PMID: 16882337 Free PMC article.
129 results
Jump to page